NCT00002059 2005-06-24A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed VolunteersNIH AIDS Clinical Trials Information ServicePhase NA Completed